USE OF BUPROPION FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING RESTLESS LEGS SYNDROME

Details for Australian Patent Application No. 2003261459 (hide)

Owner PHARMACIA AND UPJOHN COMPANY

Inventors ROBERTSON, David, W.

Pub. Number AU-A-2003261459

PCT Number PCT/US03/24795

PCT Pub. Number WO2004/017951

Priority 60/405,943 26.08.02 US

Filing date 22 August 2003

Wipo publication date 11 March 2004

International Classifications

A61K 031/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61P 025/00 Drugs for disorders of the nervous system

Event Publications

20 November 2003 Complete Application Filed

  Priority application(s): 60/405,943 26.08.02 US

22 April 2004 Application Open to Public Inspection

  Published as AU-A-2003261459

2 June 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003261460-SINGLE NUCLEOTIDE POLYMORPHISMS DIAGNOSTIC FOR SCHIZOPHRENIA

2003261458-ENHANCEMENT OF THE WETTING OF HYDROPHOBIC SURFACES BY AQUEOUS SURFACTANT SOLUTIONS